Abstract:Objective: Urinary N-acetyl-β-glucosaminidase(NAGase) and Retinal-binding protein(RBP) has been applied as sensitive clinical markers of acute tubulointerstial damage s. Further study is in need to evaluate their relevance with pathological change s and clinical functional changes in different entities of tubulointerstitial di sorders and glomerular diseases. In this study, we explored the relevance of the se markers with the tubulointerstitial lesion and glomerular function in classic al tubulointerstitial disorders as chronic aristolochic acid nephropathy (CAAN) and Sjogren syndrome related nephropathy (SSN), and in glomerulonephropathy as I gA nephropathy (IgAN) and lupus nephropathy (LN). Methodology:This study included 9 patients with SSN, 14 patients with CAAN, 169 patients wit h IgAN and 83 patients with type-Ⅳ or type-Ⅴ LN. All patients were hospitali zed for evaluation, and underwent a renal biopsy. Urinary RBP and NAGase were de termined with ELISA and colourimetric assay respectively. Other laboratory tests including urinary C3, urinary α 2M, 24 hour urinary protein excetion, and ser um creatinine (SCr) were studied. Histological changes of renal biopsy slides we re reviewed and graded semi-quantitatively according to the extent of tubulointe rstitial lesion. Changes of urinary RBP and NAG and their relationship with tubu lar interstitial damage were analyzed, with respect to the four different groups of patients. Influencing factors on urinary RBP and NAG were explored. Results:In patients with Sjogren's disease, CAAN, IgAN and LN, the percentages of patien ts with increased urine RBP and NAG were 100% and 88.89%、85.71% and 71.43 %、37.28% and 56.21%,69.88% and 97.59%, respectively. RBP and NAG excr etion increased while tubular-interstitial lesion deteriorate. In SSN and CAAN, The urinary excretion of RBP and NAG had no significant co-relationship with th at of urinary C3 and α 2M (P0.05). There is no significant change of uri nary RBP and NAG when SCr increase (P0.05). In IgAN, The excretion of RBP had significant co-relationship with that of urinary C3(P0.01), the exc retion of NAG had significant co-relationship with that of urinary C3 and α 2 M(P0.01). RBP and NAG excretion increased while 24h urine protein excret ion or SCr raised. In LN, The excretion of RBP and NAG had significant co-relat ionship with that of urinary C3 and α 2M respectively(P0.01). The excr etion of NAG increased when 24h urine protein aggrandized(P0.05)and that of RBP increased along with SCr. Conclusion:Examinations of urine RBP and NAG are effective methods for assessing renal tubu lar interstitial lesion. Urine RBP and NAG levels correlate with tubular interst itial historical change and show various characters in different nephropathies. In patients characterized by tubulointerstitial lesion, such as SSN and CAAN, ur inary RBP and urinary NAG correlated well with the extent of tubulointerstitial changes. In patients characterized by glomerular lesion and accompanied tubuloin terstitial changes, the extent of using RBP and urinary NAG are influenced by fa ctors including 24-hour urinary protein excretion, urinary protein selectivity, and serum levels of creatinine.

Investigation of messenger RNA expression of CCN2/CCN3 in the urinary sediments in patients with chronic kidney disease

Bioinformatics analysis reveals CCR7 as a potential biomarker for predicting CKD progression

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

mRNA Levels and Immunofluorescence Staining for Various Markers

The urinary RNA atlas of patients with chronic kidney disease

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

Urinary exosomes derived circRNAs as biomarkers for chronic renal fibrosis

Angiopoietin-like Protein 3: a Novel Potential Biomarker for Nephrotic Syndrome in Children

Exploring diagnostic biomarkers of type 2 cardio-renal syndrome based on secreted proteins and bioinformatics analysis

A Novel Biomarker in Differentiating MCN and MN: Urinary sCD80

Expression of urinary exosomal miRNA-615-3p and miRNA-3147 in diabetic kidney disease and their association with inflammation and fibrosis

Clinical significance of urinary neutrophil gelatinase-associated lipocalin in chronic kidney disease

Detection of miRNA in kidney biopsies of child patients with nephrotic syndrome and its significance

Urinary exosomal mRNAs as biomarkers for predicting the therapeutic effect of renin-angiotensin system inhibitors in IgA nephropathy patients

Clinical Application of the Urinary Markers of Renal Tubular Injury

VOCC and BKCa Mrna Expression in Kidney Tissues of IgA Nephropathy Patients

Diagnostic significance of hsa_circ_0000146 and hsa_circ_0000072 biomarkers for Diabetic Kidney Disease in patients with type 2 diabetes mellitus

Exploration of Early Assessment of Renal Impairment in Multiple Myeloma

Expression and Application of Serum NGAL, KIM-1 and CysC in Patients with Renal Tumor

Identification of immune-related molecular clusters and diagnostic markers in chronic kidney disease based on cluster analysis

Identification of urinary extracellular vesicles differentially expressed RNAs in diabetic nephropathy via whole-transcriptome integrated analysis